Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Education as Topic | 5 | 2025 | 452 | 1.340 |
Why?
|
| Kidney Failure, Chronic | 13 | 2025 | 924 | 1.150 |
Why?
|
| Kidney Diseases | 4 | 2011 | 479 | 0.860 |
Why?
|
| Renal Dialysis | 12 | 2025 | 932 | 0.760 |
Why?
|
| Medication Adherence | 1 | 2025 | 330 | 0.710 |
Why?
|
| Nephrology | 4 | 2012 | 153 | 0.690 |
Why?
|
| Peritoneal Dialysis | 1 | 2022 | 129 | 0.680 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 225 | 0.530 |
Why?
|
| Hyperphosphatemia | 3 | 2025 | 19 | 0.480 |
Why?
|
| Phosphates | 3 | 2025 | 109 | 0.400 |
Why?
|
| Serum Albumin | 2 | 2011 | 110 | 0.400 |
Why?
|
| Hypoalbuminemia | 1 | 2013 | 17 | 0.400 |
Why?
|
| Ergocalciferols | 2 | 2008 | 5 | 0.360 |
Why?
|
| Hyperparathyroidism, Secondary | 2 | 2008 | 16 | 0.350 |
Why?
|
| Bone Density Conservation Agents | 2 | 2008 | 57 | 0.340 |
Why?
|
| Internet | 3 | 2011 | 400 | 0.340 |
Why?
|
| Patient Satisfaction | 2 | 2011 | 457 | 0.330 |
Why?
|
| Patients | 1 | 2011 | 122 | 0.320 |
Why?
|
| Renal Replacement Therapy | 1 | 2011 | 158 | 0.300 |
Why?
|
| Nutrition Assessment | 1 | 2010 | 125 | 0.300 |
Why?
|
| Consumer Health Information | 1 | 2008 | 28 | 0.270 |
Why?
|
| Reimbursement, Incentive | 1 | 2008 | 48 | 0.270 |
Why?
|
| Medical Records | 1 | 2008 | 178 | 0.260 |
Why?
|
| Disclosure | 1 | 2008 | 148 | 0.260 |
Why?
|
| Minerals | 1 | 2007 | 58 | 0.250 |
Why?
|
| Bone Diseases | 1 | 2007 | 42 | 0.250 |
Why?
|
| Health Resources | 1 | 2008 | 127 | 0.250 |
Why?
|
| Physicians | 2 | 2012 | 618 | 0.230 |
Why?
|
| Quality Improvement | 1 | 2011 | 681 | 0.230 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 56 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 883 | 0.220 |
Why?
|
| Medicare | 1 | 2008 | 421 | 0.220 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 795 | 0.210 |
Why?
|
| Diarrhea | 1 | 2025 | 306 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2005 | 222 | 0.190 |
Why?
|
| Ferric Compounds | 2 | 2015 | 38 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2025 | 561 | 0.160 |
Why?
|
| Chronic Disease | 3 | 2010 | 1194 | 0.150 |
Why?
|
| Humans | 22 | 2025 | 126547 | 0.150 |
Why?
|
| Information Services | 1 | 1998 | 20 | 0.140 |
Why?
|
| Computer Communication Networks | 1 | 1998 | 16 | 0.140 |
Why?
|
| Middle Aged | 10 | 2025 | 27515 | 0.130 |
Why?
|
| Chelating Agents | 1 | 2015 | 50 | 0.110 |
Why?
|
| Aged | 6 | 2025 | 20159 | 0.110 |
Why?
|
| Male | 11 | 2025 | 62352 | 0.100 |
Why?
|
| Dialysis | 1 | 2012 | 18 | 0.100 |
Why?
|
| Female | 10 | 2025 | 68177 | 0.100 |
Why?
|
| Professional Misconduct | 1 | 2012 | 34 | 0.100 |
Why?
|
| Adult | 7 | 2025 | 30335 | 0.090 |
Why?
|
| Voluntary Health Agencies | 1 | 2011 | 5 | 0.090 |
Why?
|
| Biomarkers | 2 | 2011 | 3142 | 0.090 |
Why?
|
| Bone Remodeling | 1 | 2011 | 55 | 0.090 |
Why?
|
| Access to Information | 1 | 2011 | 45 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2011 | 121 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 131 | 0.080 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 236 | 0.080 |
Why?
|
| United States | 4 | 2011 | 11253 | 0.080 |
Why?
|
| Hemoglobins | 2 | 2011 | 310 | 0.080 |
Why?
|
| DNA Fingerprinting | 1 | 2010 | 104 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2011 | 281 | 0.080 |
Why?
|
| Nasal Cavity | 1 | 2010 | 52 | 0.080 |
Why?
|
| Ethics, Medical | 1 | 2012 | 399 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2011 | 299 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12504 | 0.070 |
Why?
|
| Voluntary Programs | 1 | 2008 | 2 | 0.070 |
Why?
|
| Foundations | 1 | 2008 | 23 | 0.070 |
Why?
|
| Organizations, Nonprofit | 1 | 2008 | 26 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 231 | 0.070 |
Why?
|
| Malnutrition | 1 | 2010 | 150 | 0.070 |
Why?
|
| Hematocrit | 1 | 2008 | 109 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 132 | 0.070 |
Why?
|
| Anemia | 1 | 2011 | 338 | 0.070 |
Why?
|
| Calcium | 2 | 2015 | 1031 | 0.070 |
Why?
|
| Patient Selection | 1 | 2011 | 707 | 0.070 |
Why?
|
| Calcifediol | 1 | 2007 | 13 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 138 | 0.070 |
Why?
|
| Benchmarking | 1 | 2008 | 129 | 0.060 |
Why?
|
| Urea | 1 | 2008 | 225 | 0.060 |
Why?
|
| Hyperparathyroidism | 1 | 2007 | 26 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2007 | 38 | 0.060 |
Why?
|
| Phosphorus | 1 | 2007 | 60 | 0.060 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 77 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2007 | 98 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1370 | 0.060 |
Why?
|
| Kidney | 3 | 2011 | 1282 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 693 | 0.060 |
Why?
|
| Vitamin D | 1 | 2007 | 175 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 529 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2007 | 222 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 746 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1594 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1231 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 77 | 0.050 |
Why?
|
| Bone Density | 1 | 2007 | 351 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2024 | 41 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2008 | 730 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2004 | 92 | 0.050 |
Why?
|
| Iron-Dextran Complex | 1 | 2002 | 3 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2024 | 278 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2004 | 1308 | 0.050 |
Why?
|
| Quality of Life | 1 | 2011 | 2026 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 3909 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1102 | 0.040 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2002 | 136 | 0.040 |
Why?
|
| Young Adult | 2 | 2011 | 9652 | 0.040 |
Why?
|
| Saralasin | 1 | 1979 | 1 | 0.040 |
Why?
|
| Hypertension, Renovascular | 1 | 1979 | 28 | 0.040 |
Why?
|
| Hypertension, Renal | 1 | 1979 | 31 | 0.040 |
Why?
|
| Angiotensin II | 1 | 1979 | 136 | 0.040 |
Why?
|
| Calcium Compounds | 1 | 2015 | 7 | 0.030 |
Why?
|
| Sevelamer | 1 | 2015 | 11 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2010 | 6125 | 0.030 |
Why?
|
| Polyamines | 1 | 2015 | 35 | 0.030 |
Why?
|
| Acetates | 1 | 2015 | 80 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 222 | 0.030 |
Why?
|
| Marketing of Health Services | 1 | 2012 | 24 | 0.020 |
Why?
|
| Adolescent | 1 | 2011 | 19983 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2012 | 64 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 142 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 6595 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2006 | 1574 | 0.020 |
Why?
|
| Informed Consent | 1 | 2012 | 336 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 430 | 0.020 |
Why?
|
| Regional Blood Flow | 3 | 2004 | 194 | 0.020 |
Why?
|
| Capsules | 1 | 2006 | 21 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 556 | 0.010 |
Why?
|
| Transducers | 1 | 2004 | 22 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 176 | 0.010 |
Why?
|
| Placebos | 1 | 2002 | 224 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1979 | 152 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2002 | 324 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2002 | 86 | 0.010 |
Why?
|
| Acute Kidney Injury | 2 | 1979 | 664 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 203 | 0.010 |
Why?
|
| Hypotension | 1 | 2002 | 180 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1982 | 223 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 2105 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 78 | 0.010 |
Why?
|
| Renin | 1 | 1979 | 73 | 0.010 |
Why?
|
| Blood Volume | 1 | 1979 | 71 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1977 | 8 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1979 | 172 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1977 | 93 | 0.010 |
Why?
|
| Inulin | 2 | 1979 | 17 | 0.000 |
Why?
|
| Dogs | 2 | 1979 | 603 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1982 | 70 | 0.000 |
Why?
|
| Uremia | 1 | 1982 | 38 | 0.000 |
Why?
|
| Gastroscopy | 1 | 1982 | 95 | 0.000 |
Why?
|
| Rectum | 1 | 1982 | 99 | 0.000 |
Why?
|
| Benzolamide | 1 | 1979 | 1 | 0.000 |
Why?
|
| Secretin | 1 | 1979 | 12 | 0.000 |
Why?
|
| Chlorothiazide | 1 | 1979 | 11 | 0.000 |
Why?
|
| Furosemide | 1 | 1979 | 32 | 0.000 |
Why?
|
| Bradykinin | 1 | 1979 | 45 | 0.000 |
Why?
|
| Mannitol | 1 | 1979 | 40 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1979 | 147 | 0.000 |
Why?
|
| Time Factors | 2 | 1979 | 6099 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1979 | 270 | 0.000 |
Why?
|
| Sodium | 1 | 1979 | 274 | 0.000 |
Why?
|
| Uranium | 1 | 1977 | 6 | 0.000 |
Why?
|
| Kidney Cortex | 1 | 1977 | 19 | 0.000 |
Why?
|
| Creatinine | 1 | 1977 | 379 | 0.000 |
Why?
|
| Animals | 2 | 1979 | 33183 | 0.000 |
Why?
|